Skip to main content

NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Michael J. Tarlov (Fed)

Michael Tarlov is chief of the Biomolecular Measurement Division, which develops the measurement science, standards, technology, and data required to support the nation's needs for determining the composition, structure, quantity, and function of biomolecules. This work will help to advance biotechnology, DNA forensics, biomedical and bioscience research, and health care. Mike Tarlov received a Ph.D. in analytical chemistry from the University of Minnesota. During his career at NIST he has authored or co-authored more than 80 publications in the areas of self-assembled monolayers, biochemical sensing, and bioprocess measurements.  Mike was formerly chief of the Process Measurements Division, and was acting chief of the Biochemical Science Division.  Mike is also responsible for leading the cross-division NIST Biomanufacturing Program, which develops measurement science, standards, and reference data to support the development, manufacturing, and regulatory approval of protein drugs.

PROFESSIONAL AFFILIATIONS

American Chemical Society (Member of Biochemical Technology, Colloid and Surface Science Divisions)            
Parenteral Drug Association
American Society for Mass Spectrometry

HONORS  

Department of Commerce Silver Medal, 2004

Selected Publications

Publications

Interlaboratory Studies using the NISTmAb to Advance Biopharmaceutical Structural Analytics

Author(s)
Katharina Yandrofski, Trina Mouchahoir, M. Lorna De Leoz, David L. Duewer, Jeffrey W. Hudgens, Kyle Anderson, Luke Arbogast, Frank Delaglio, Robert Brinson, John Marino, Karen W. Phinney, Michael J. Tarlov, John E. Schiel
Biopharmaceuticals such as monoclonal antibodies are required to be rigorously characterized using a wide range of analytical methods. Various material
Created October 9, 2019, Updated December 8, 2022
Was this page helpful?